Metoject 15 mg / 0.30 ml is a prefilled syringe containing methotrexate, widely used in rheumatology, dermatology, and oncology to manage autoimmune and inflammatory diseases.
It offers precise dosing, improved bioavailability, and greater convenience compared to oral methotrexate.
Methotrexate:
❗ Must be used once weekly only, not daily.
Metoject vs Methotrexate Tablets
| Feature | Metoject (Injection) | Methotrexate Tablets |
|---|---|---|
| Form | Pre-filled syringe (subcutaneous) | Oral tablets |
| Bioavailability | High and consistent | May decrease at higher doses |
| Absorption | Independent of GI tract | Affected by digestion |
| Frequency | Once weekly | Once weekly |
| Ease of use | Requires injection technique | Easy oral intake |
| GI side effects | Minimal | Common (nausea, irritation) |
| Dose accuracy | Very precise | Can vary |
| Best for | Poor tolerance to tablets | Mild cases |
An injectable methotrexate formulation.
Once per week.
Often yes — better absorption and tolerance.
Yes, usually recommended.
Yes, after proper training.
Задайте вопрос или уточните условия доставки в вашу страну





